Chadi Nabhan, MD, MBA, FACP; Yolaine Jeune-Smith, PhD; Peter Klinefelter, BA; Jennifer Fillman, MBA; Bruce A. Feinberg, DO

The potential impact of CAR-T therapies should not be underestimated, nor should their complexity, which is why a broader understanding of stakeholder knowledge and perception may be critical to their adoption and use.